DiC14-amidine confers new anti-inflammatory properties to phospholipids

Cellular and Molecular Life Sciences

Volumn 65, Issue 4, 2008, Pages 620-630

  Lonez, C ^a   Legat, A ^a   Vandenbranden, M ^a   Ruysschaert, J M ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Anti inflammatory; Cationic lipids; CpG sequences; Phospholipids; TNF

Indexed keywords

AMIDINE; DIC14 AMIDINE; LIPOSOME; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CATION TRANSPORT; DNA SEQUENCE; GENE THERAPY; HUMAN; LIPID OXIDATION;

AMIDINES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CYTOKINES; HUMANS; INFLAMMATION; LIPOSOMES; PHOSPHOLIPIDS;

EID: 39749184365     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7520-1     Document Type: Article

References (48)

1. Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M. and Danielsen, M. (1987) Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84, 7413-7417.
2. Martin, B., Sainlos, M., Aissaoui, A., Oudrhiri, N., Hauchecorne, M., Vigneron, J. P., Lehn, J. M. and Lehn, P. (2005) The design of cationic lipids for gene delivery. Curr. Pharm. Des. 11, 375-394.
3. Karmali, P. P. and Chaudhuri, A. (2006) Cationic liposomes as non-viral carriers of gene medicines: Resolved issues, open questions, and future promises. Med. Res. Rev. 27, 696-722.
4. Elouahabi, A. and Ruysschaert, J. M. (2005) Formation and intracellular trafficking of lipoplexes and polyplexes. Mol. Ther. 11, 336-347.
5. Zuhorn, I. S., Engberts, J. B. and Hoekstra, D. (2007) Gene delivery by cationic lipid vectors: Overcoming cellular barriers. Eur. Biophys. J. 36, 349-362.
6. Wasungu, L. and Hoekstra, D. (2006) Cationic lipids, lipoplexes and intracellular delivery of genes. J. Control. Release 116, 255-264.
7. Liu, F., Qi, H., Huang, L. and Liu, D. (1997) Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther. 4, 517-523.
8. Templeton, N. S., Lasic, D. D., Frederik, P. M., Strey, H. H., Roberts, D. D. and Pavlakis, G. N. (1997) Improved DNA: Liposome complexes for increased systemic delivery and gene expression. Nat. Biotechnol. 15, 647-652.
9. McLean, J. W., Fox, E. A., Baluk, P., Bolton, P. B., Haskell, A., Pearlman, R., Thurston, G., Umemoto, E. Y. and McDonald, D. M. (1997) Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am. J. Physiol. 273, H387-H404.
10. Escriou, V., Ciolina, C., Lacroix, F., Byk, G., Scherman, D. and Wils, P. (1998) Cationic lipid-mediated gene transfer: Effect of serumon cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim. Biophys. Acta 1368, 276-288.
11. Li, S., Tseng, W. C., Stolz, D. B., Wu, S. P., Watkins, S. C. and Huang, L. (1999) Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: Implications for intravenous lipofection. Gene Ther. 6, 585-594.
12. Tandia, B. M., Lonez, C., Vandenbranden, M., Ruysschaert, J. M. and Elouahabi, A. (2005) Lipid mixing between lipoplexes and plasma lipoproteins is a major barrier for intravenous transfection mediated by cationic lipids. J. Biol. Chem. 280, 12255-12261.
13. Tandia, B. M., Vandenbranden, M., Wattiez, R., Lakhdar, Z., Ruysschaert, J. M. and Elouahabi A. (2003) Identification of human plasma proteins that bind to cationic lipid/DNA complex and analysis of their effects on transfection efficiency: Implications for intravenous gene transfer. Mol. Ther. 8, 264-273.
14. Son, K. K., Patel, D. H., Tkach, D. and Park, A. (2000) Cationic liposome and plasmid DNA complexes formed in serum-free medium under optimum transfection condition are negatively charged. Biochim. Biophys. Acta 1466, 11-15.
15. Li, S., Wu, S. P., Whitmore, M., Loeffert, E. J., Wang, L., Watkins, S. C., Pitt, B. R. and Huang, L. (1999) Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am. J. Physiol. 276, L796-804.
16. Dow, S. W., Fradkin, L. G., Liggitt, D. H., Willson, A. P., Heath, T. D. and Potter, T. A. (1999) Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J. Immunol. 163, 1552-1561.
17. Zhao, H., Hemmi, H., Akira, S., Cheng, S. H., Scheule, R. K. and Yew, N. S. (2004) Contribution of Toll-like receptor 9 signaling to the acute inflammatory response to nonviral vectors. Mol. Ther. 9, 241-248.
18. Yew, N. S., Wang, K. X., Przybylska, M., Bagley, R. G., Stedman, M., Marshall, J., Scheule, R. K. and Cheng, S. H. (1999) Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. Hum Gene Ther. 10, 223-234.
19. Zhang, J. S., Liu, F. and Huang, L. (2005) Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. Adv. Drug Deliv. Rev. 57, 689-698.
20. Liu, F., Shollenberger, L. M. and Huang, L. (2004) Non-immunostimulatory nonviral vectors. FASEBJ. 18, 1779-1781.
21. Defrise-Quertain, F., Duquenoy, P., Brasseur, R., Brak, P., Caillaux, B., Fuks, R. and Ruysschaert, J. M. (1986) Vesicle formation by double long-chain amidines. J. Chem. Soc. Chem. Commun. 14, 1060-1062.
22. Ruysschaert, J. M., el Ouahabi, A., Willeaume, V., Huez, G., Fuks, R., Vandenbranden, M. and Di Stefano, P. (1994) A novel cationic amphiphile for transfection of mammalian cells. Biochem. Biophys. Res. Commun. 203, 1622-1628.
23. Pector, V., Backmann, J., Maes, D., Vandenbranden, M. and Ruysschaert, J. M. (2000) Biophysical and structural properties of DNA. diC(14)-amidine complexes. Influence of the DNA/lipid ratio. J. Biol. Chem. 275, 29533-29538.
24. Pector, V., Caspers, J., Banerjee, S., Deriemaeker, L., Fuks, R., El Ouahabi, A., Vandenbranden, M., Finsy, R. and Ruysschaert, J. M. (1998) Physico-chemical characterization of a double long-chain cationic amphiphile (Vectamidine) by microelectrophoresis. Biochim. Biophys. Acta 1372, 339-346.
25. Elouahabi, A., Flamand, V., Ozkan, S., Paulart, F., Vandenbranden, M., Goldman, M. and Ruysschaert, J. M. (2003) Free cationic liposomes inhibit the inflammatory response to cationic lipid-DNA complex injected intravenously and enhance its transfection efficiency. Mol. Ther. 7, 81-88.
26. Lonez, C., Vandenbranden, M., Ouali, M., Legat, A., Ruysschaert, J. M. and Elouahabi, A. (2006) Free diC14-amidine liposomes inhibit the TNF-alpha secretion induced by CpG sequences and lipopolysaccharides: Role of lipoproteins. Mol. Membr. Biol. 23, 227-234.
27. Chapman, M. J., Goldstein, S., Lagrange, D. and Laplaud, P. M. (1981) A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J. Lipid Res. 22, 339-358.
28. Osborne, J. C. Jr. (1986) Delipidation of plasma lipoproteins. Methods Enzymol. 128, 213-222.
29. Watson, A. D., Leitinger, N., Navab, M., Faull, K. F., Horkko, S., Witztum, J. L., Palinski, W., Schwenke, D., Salomon, R. G., Sha, W., Subbanagounder, G., Fogelman, A. M. and Berliner, J. A. (1997) Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272, 13597-13607.
30. Leitinger, N., Tyner, T. R., Oslund, L., Rizza, C., Subbanagounder, G., Lee, H., Shih, P. T., Mackman, N., Tigyi, G., Territo, M. C., Berliner, J. A. and Vora, D. K. (1999) Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc. Natl. Acad. Sci. USA 96, 12010-12015.
31. Bochkov, V. N., Mechtcheriakova, D., Lucerna, M., Huber, J., Malli, R., Graier, W. F., Hofer, E., Binder, B. R. and Leitinger, N. (2002) Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT. Blood 99, 199-206.
32. Subbanagounder, G., Leitinger, N., Schwenke, D. C., Wong, J. W., Lee, H., Rizza, C., Watson, A. D., Faull, K. F., Fogelman, A. M. and Berliner, J. A. (2000) Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arterioscler. Thromb. Vasc. Biol. 20, 2248-2254.
33. Ma, Z., Li, J., Yang, L., Mu, Y., Xie, W., Pitt, B. and Li, S. (2004) Inhibition of LPS- and CpG DNA-induced TNF-alpha response by oxidized phospholipids. Am. J. Physiol. Lung Cell. Mol. Physiol. 286, L808-L816.
34. Walton, K. A., Gugiu, B. G., Thomas, M., Basseri, R. J., Eliav, D. R., Salomon, R. G. and Berliner, J. A. (2006) A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products. J. Lipid Res. 47, 1967-1974.
35. Miller, Y. I., Chang, M. K., Binder, C. J., Shaw, P. X. and Witztum, J. L. (2003) Oxidized low density lipoprotein and innate immune receptors. Curr. Opin. Lipidol. 14, 437-445.
36. Davies, S. S., Pontsler, A. V., Marathe, G. K., Harrison, K. A., Murphy, R. C., Hinshaw, J. C., Prestwich, G. D., Hilaire, A. S., Prescott, S. M., Zimmerman, G. A. and McIntyre, T. M. (2001) Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J. Biol. Chem. 276, 16015-16023.
37. Birukov, K. G., Leitinger, N., Bochkov, V. N. and Garcia, J. G. (2004) Signal transduction pathways activated in human pulmonary endothelial cells by OxPAPC, a bioactive component of oxidized lipoproteins. Microvasc. Res. 67, 18-28.
38. van der Kleij, D., Latz, E., Brouwers, J. F., Kruize, Y. C., Schmitz, M., Kurt-Jones, E. A., Espevik, T., de Jong, E. C., Kapsenberg, M. L., Golenbock, D. T., Tielens A. G. and Yazdanbakhsh, M. (2002) A novel host-parasite lipid crosstalk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 277, 48122-48129.
39. Hashimoto, M., Asai, Y. and Ogawa, T. (2003) Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns. J. Biol. Chem. 278, 44205-44213.
40. Wu, Y. Z., Medjane, S., Chabot, S., Kubrusly, F. S., Raw, I., Chignard, M. and Touqui, L. (2003) Surfactant protein-A and phosphatidylglycerol suppress type IIA phospholipase A2 synthesis via nuclear factor-kappaB. Am. J. Respir. Crit. Care Med. 168, 692-699.
41. Otsuka, M., Negishi, Y. and Aramaki, Y. (2007) Involvement of phosphatidylinositol-3-kinase and ERK pathways in the production of TGF-beta1 by macrophages treated with liposomes composed of phosphatidylserine. FEBS Lett. 581, 325-330.
42. Huynh, M. L., Fadok, V. A. and Henson, P. M. (2002) Phosphatidylserine- dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109, 41-50.
43. Tonks, A., Morris, R. H., Price, A. J., Thomas, A. W., Jones, K. P. and Jackson, S. K. (2001) Dipalmitoylphosphatidylcholine modulates inflammatory functions of monocytic cells independently of mitogen activated protein kinases. Clin. Exp. Immunol. 124, 86-94.
44. Kamiya, H., Fujimura, Y., Matsuoka, I. and Harashima, H. (2002) Visualization of intracellular trafficking of exogenous DNA delivered by cationic liposomes. Biochem. Biophys. Res. Commun. 298, 591-597.
45. Cao, A., Briane, D., Coudert, R., Vassy, J., Lievre, N., Olsman, E., Tamboise, E., Salzmann, J. L., Rigaut, J. P. and Taillandier, E. (2000) Delivery and pathway in MCF7 cells of DNA vectorized by cationic liposomes derived from cholesterol. Antisense Nucleic Acid Drug Dev. 10, 369-380.
46. Friend, D. S., Papahadjopoulos, D. and Debs, R. J. (1996) Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim. Biophys. Acta 1278, 41-50.
47. Daynes, R. A. and Jones, D. C. (2002) Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol. 2, 748-759.
48. Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H. and Evans, R. M. (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93, 229-240.